EUVIMEDEUVIMED entdecken
Crossref

Alternative viewpoint against diabetic wound based on stem cell secretome that can mediated angiogenesis and reduce inflammation

Rezvan Izadi, Seyed Hesamaldin Hejazi, Seifollah Bahramikia

Archives of Dermatological Research · 2023

DOI: 10.1007/s00403-023-02739-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Dermatological Research, 2023. Verfasst von Rezvan Izadi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Basic Sciences, Lorestan University, Khorramabad, Iran. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor A, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus, as an important metabolic disorder, affects the health of millions of people worldwide. A diabetic wound is one of the complications of diabetes. The stem cell secretome can particularly affect the wound healing process in diabetic wounds. The present study aimed to investigate the effects of Adipose-derived stem cells (ASCs) secretome on the skin wound healing process, angiogenesis, and inflammation in diabetic rats. For this purpose, ASCs were extracted from Adipose tissue and confirmed by flow cytometry and cell differentiation. Secretome was prepared. 27 rats were divided into three groups, non-diabetic, diabetic (treated with phosphate-buffered saline), and diabetics treated with secretome. The levels of vascular endothelial growth factor (VEGF) and transforming growth factor-beta (TGF-β) were examined by the enzyme-linked immunosorbent assay (ELISA) was performed in the skin tissues of all groups. Hematoxylin and eosin (H&E) staining was performed. The level of VEGF was higher in the diabetic group treated with secretome as compared to the other two groups, while the level of TGF-β was lower in this group, compared to the diabetic group. Based on the results of H&E staining, the epidermal thickness and angiogenesis were higher in the diabetic group treated with secretome, whereas edema, number of inflammatory cells, and epidermal damage were lower in this group, compared to the diabetic group. Subcutaneous injection of secretome can lead to diabetic wound healing by increasing growth factors associated with angiogenesis such as VEGF, increasing angiogenesis, regulating TGF-β levels, reducing inflammatory cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor ADiabetes Mellitus, ExperimentalHumansRatsAnimalsSecretomeStem CellsNeovascularization, PhysiologicTransforming Growth Factor betaInflammation

Stichwörter der Autor:innen

AngiogenesisDiabetic woundInflammationSecretomeStem cellWound healing

Substanzen

Vascular Endothelial Growth Factor ATransforming Growth Factor beta

Autor:innen und Institutionen

  • Department of Biology, Faculty of Basic Sciences, Lorestan University, Khorramabad, Iran.
  • Department of Biology, Faculty of Basic Sciences, Lorestan University, Khorramabad, Iran. Hejazi.h@lu.ac.ir.

Zitieren

APA

Izadi, R., Hejazi, S. H., & Bahramikia, S. (2023). Alternative viewpoint against diabetic wound based on stem cell secretome that can mediated angiogenesis and reduce inflammation. Archives of Dermatological Research. https://doi.org/10.1007/s00403-023-02739-7

Vancouver

Izadi R, Hejazi SH, Bahramikia S. Alternative viewpoint against diabetic wound based on stem cell secretome that can mediated angiogenesis and reduce inflammation. Archives of Dermatological Research. 2023. doi:10.1007/s00403-023-02739-7

BibTeX
@article{Izadi2023,
  author = {Izadi, Rezvan and Hejazi, Seyed Hesamaldin and Bahramikia, Seifollah},
  title = {Alternative viewpoint against diabetic wound based on stem cell secretome that can mediated angiogenesis and reduce inflammation},
  journal = {Archives of Dermatological Research},
  year = {2023},
  doi = {10.1007/s00403-023-02739-7}
}
Kostenlos starten →